|
Search
Collections
Benchmarks
Upload document
Product
TransCon hGH
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
5 indications
Indication
Growth Hormone Deficiency
Indication
Pediatric
Indication
Endocrine System Diseases
Indication
Hormone Deficiency
Indication
Pituitary Disorders
Clinical trial
enliGHten: A Multicenter, Phase 3, Long-Term, Open-Label Trial Investigating Safety and Efficacy of TransCon hGH Administered Once-Weekly in Children With Growth Hormone Deficiency (GHD) Who Have Completed a Prior TransCon hGH Clinical Trial
Status: Completed
, Estimated PCD: 2023-02-21